Tomocube, Inc. (KOSDAQ:475960)

South Korea flag South Korea · Delayed Price · Currency is KRW
61,700
-1,000 (-1.59%)
At close: Dec 5, 2025
390.07%
Market Cap 821.95B
Revenue (ttm) 7.23B
Net Income (ttm) -7.93B
Shares Out 13.32M
EPS (ttm) -615.13
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 743,164
Average Volume 559,506
Open 62,700
Previous Close 62,700
Day's Range 60,400 - 63,300
52-Week Range 11,990 - 63,900
Beta n/a
RSI 77.13
Earnings Date Nov 14, 2025

About Tomocube

Tomocube, Inc. engages in the manufacture and sale of optical devices and medical equipment. Its holotomography (HT) products include HT-X1 for live-cell imaging and analysis; and HT-2H for 3D live cell imaging. The company also offers TomoAnalysis, a 3D image visualization and analysis software. In addition, it provides accessories, such as HT-ready 96 well plates; TomoDish that is designed to accommodate both adherent and suspension cells; TomoChamber, a stage-top incubator designed for long-term live cell imaging; TomoPlate, an active vibrat... [Read more]

Industry Laboratory Apparatus and Furniture
Founded 2015
Employees 65
Stock Exchange KOSDAQ
Ticker Symbol 475960
Full Company Profile

Financial Performance

In 2024, Tomocube's revenue was 5.94 billion, an increase of 58.48% compared to the previous year's 3.75 billion. Losses were -8.30 billion, -64.75% less than in 2023.

Financial Statements

News

There is no news available yet.